共 37 条
[21]
Sahin IH(2002)Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials BMJ 324 813-2115
[22]
Schøler LV(2018)Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer JAMA 319 2104-341
[23]
Renehan AG(2020)IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2 Study protocol Acta Oncol 59 336-33
[24]
Snyder RA(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-975
[25]
Nors J(2021)Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status Br J Surg 108 968-301
[26]
Siegel RL(2012)Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors Clin Epidemiol 4 283-4982
[27]
Kawaguchi Y(2006)Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 4976-1970
[28]
Kanas GP(2009)A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer Ann Oncol 20 1964-1215
[29]
Portier G(2013)Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Lancet Oncol 14 1208-411
[30]
Ychou M(2020)Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial Lancet Oncol 21 398-1832